WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001030353) USE OF DIPYRIDAMOLE OR MOPIDAMOL IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT AND PREVENTION OF FIBRIN-DEPENDENT MICROCIRCULATION DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2001/030353 International Application No.: PCT/EP2000/010123
Publication Date: 03.05.2001 International Filing Date: 14.10.2000
Chapter 2 Demand Filed: 09.02.2001
IPC:
A61K 31/519 (2006.01) ,A61K 45/06 (2006.01)
Applicants: EISERT, Wolfgang[DE/DE]; DE (UsOnly)
BOEHRINGER INGELHEIM PHARMA KG[DE/DE]; 55218 Ingelheim/Rhein, DE (AllExceptUS)
Inventors: EISERT, Wolfgang; DE
Agent: LAUDIEN, Dieter; Boehringer Ingelheim GmbH CD Patents 55216 Ingelheim/Rhein, DE
Priority Data:
99121121.022.10.1999EP
Title (EN) USE OF DIPYRIDAMOLE OR MOPIDAMOL IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT AND PREVENTION OF FIBRIN-DEPENDENT MICROCIRCULATION DISORDERS
(FR) UTILISATION DE DIPYRIDAMOLE OU DE MOPIDAMOL DANS LA FABRICATION D'UN MEDICAMENT DE TRAITEMENT ET DE PREVENTION DE TROUBLES DE LA MICROCIRCULATION LIES A LA FIBRINE
Abstract:
(EN) A method of treatment of the human or non-human animal body for treating fibrin-dependent microcirculation disorders is disclosed, for example microcirculation disorders caused by metabolic diseases, inflammatory reactions or autoimmune diseases, furthermore peripheral microcirculation disorders or microcirculation disorders associated with increased cell fragmentation, which method comprises administering to a human or non-human animal body in need of such treatment an effective amount of a pharmaceutical composition containing a pyrimido-pyrimidine selected from dipyridamole, mopidamol and the pharmaceutically acceptable salts thereof, and the use of said pyrimido-pyrimidine for the manufacture of a corresponding pharmaceutical composition.
(FR) L'invention concerne un traitement de médecine animale ou vétérinaire dirigé contre les troubles de la microcirculation liés à la fibrine, notamment en raison de maladies du métabolisme, mais aussi contre des réactions inflammatoires ou des maladies auto-immunes, ainsi que des troubles de la microcirculation périphérique ou associés à une augmentation de la fragmentation cellulaire. A cet effet, on administre au sujet une quantité suffisante d'une composition pharmaceutique contenant une pyrimido-pyrimidine choisie parmi les dipyridamole et mopidamol et certains de leurs sels pharmaceutiquement admis. L'invention concerne également l'utilisation de cette pyrimido-pyrimidine pour la fabrication d'une composition pharmaceutique correspondante.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)